Source: Dubai – Arabic.net
Millions of people around the world pin their hopes on an effective vaccine or treatment, putting an end to the virus that has swept the world since it appeared in the Chinese city of Wuhan in December last year.
Although dozens of companies and institutions around the world have raced to reach a vaccine against Corona, eyes are turning to next fall after many statements that suggested that the vulva is coming with this date.
The new day came from a Belgian institute, where the Riga Institute, a Belgian laboratory, hoped to launch a clinical trial of the emerging coronavirus vaccine, after scientists at the University of Louvain confirmed that they had developed it and looked promising.
What is also striking this time is that the vaccine that the developers gave the name “Riga fax” in relation to the laboratory in which research and experiments are to be conducted, based on an old vaccine that was used against yellow fever.
The specialized team announced that this is the first test that “has proven successful in laboratory animals.”
Before the end of the year
“If things go according to plan, we want to start the first human clinical trials before the end of the year,” said Kay Dalmire, one of the researchers who worked on the vaccine.
The Belgian researchers first tested the corona virus vaccine on hamsters, through their airways to test a lung infection similar to that occurring in normal life during the pandemic, and they observed that hamsters vaccinated with the vaccine adapted from the yellow fever vaccine did not give any trace of the emerging corona virus that was previously injected with it. .
They also noted that a single dose of the vaccine was sufficient and that many animals were already immunized after only 10 days of vaccination.
“We started working on eight prototypes shortly after January 12, when Chinese researchers shared the genetic code of the virus over the Internet,” said Johann Knits, a professor of virology at the University of Louvain, Belgium, and head of operations at the Riga Laboratory. He continued, “We are happy with the results, although there is still a long way to go.”
It is noteworthy that the chief expert of infectious diseases in the United States, Anthony Fawcci, expressed his hope last Thursday for the availability of a vaccine for the new Corona virus at the end of 2020 or the beginning of 2021, despite his previous skepticism about the possibility of obtaining an effective vaccine before the end of this year.